“…In recent years, several protocols have been reported to propagate human myogenic progenitors from pluripotent cell sources and to differentiate these progenitors into the skeletal muscle cell lineage as myoblasts or myotubes (Zhu et al, 2014). While many protocols require cell sorting and/or rely on exogenous expression of myogenic genes such as PAX3, PAX7, and MYOD (Abujarour et al, 2014; Darabi et al, 2012; Maffioletti et al, 2015; Skoglund et al, 2014; Tanaka et al, 2013), more recent advances have been made with the application of small molecules and growth factors to directly promote myogenic differentiation from human iPSCs (Barberi et al, 2007; Borchin et al, 2013; Caron et al, 2016; Chal et al, 2016; Chal et al, 2015; Choi et al, 2016; Hosoyama et al, 2014; Hwang et al, 2013; Shelton et al, 2014; Xu et al, 2013).…”